Analystreport

Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating on the stock.

Crinetics Pharmaceuticals, Inc.  (CRNX) 
Last crinetics pharmaceuticals, inc. earnings: 3/9 04:10 pm Check Earnings Report